Ketamine (clinically supervised)
There's solid evidence that ketamine can lift depression quickly, working through a burst of brain plasticity (NMDA → glutamate → BDNF/mTOR → new synaptic connections) rather than the slow route older antidepressants take. Two honest caveats: as it acts, ketamine actually raises heart rate and blood pressure — the settled, okay-to-exist feeling is a post-session, psychological effect (relief from rumination, a looser sense of self), not a calming of the body in the moment. And ketamine-assisted psychotherapy specifically — the therapy wrapped around the dose — has much thinner evidence than the drug effect itself.
- Who it tends to fit
- People in supervised treatment — often for depression that hasn't responded to other things — for whom a short, plasticity-opening reset, with integration afterward, is appropriate.
- Who it may not fit
- Anyone seeking it outside clinical supervision; people with uncontrolled cardiovascular disease, bladder problems, or a history of substance dependence (repeated non-clinical use carries real bladder-toxicity and dependence risk).
- Cost & access
- Clinic- or prescriber-administered; typically hundreds of dollars per session. Esketamine (Spravato) is FDA-approved; IV/oral racemic ketamine is used off-label under supervision.
- Legal status
- Prescription-only, and only in a supervised clinical setting
- Credentials
- Practitioners are licensed clinicians
Ketamine is a dissociative anesthetic that, at lower doses and under supervision, can rapidly ease depression. It’s the one door on this page that has a legitimate, prescribed, clinical form — which is exactly how it should be approached.
The most useful way to hold it: ketamine can show you the room. Many people describe a window afterward where the usual grinding self-talk is quieter and the body feels more livable. But a glimpse is a reference, not a destination — the lasting change comes from what’s built in the days and weeks after, through integration and slower, repeatable practice. This site can’t and won’t offer dosing, sourcing, or how-to; that conversation belongs with a qualified clinician.
Free first steps
- The free practices here — a longer exhale, or hold-tense-and-release — reach the same kind of settling with none of the cost or risk
- If depression is what's driving the search, a clinician is the right first conversation, not a supplement or a protocol
Last reviewed 2026-07-04.